Making the effect visible - OX40 targeting nanobodies for in vivo imaging of activated T cells.
Saved in:
| Title: | Making the effect visible - OX40 targeting nanobodies for in vivo imaging of activated T cells. |
|---|---|
| Authors: | Frecot DI; Pharmaceutical Biotechnology, University Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Blaess S; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, University of Tübingen, Tübingen, Germany., Wagner TR; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Kaiser PD; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Traenkle B; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Fandrich M; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Jakobi M; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Scholz AM; Livestock Center of the Faculty of Veterinary Medicine, Ludwig Maximilians University Munich, Oberschleissheim, Germany., Nueske S; Livestock Center of the Faculty of Veterinary Medicine, Ludwig Maximilians University Munich, Oberschleissheim, Germany., Schneiderhan-Marra N; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Gouttefangeas C; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Institute for Immunology, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany., Kneilling M; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, University of Tübingen, Tübingen, Germany.; Department of Dermatology, University of Tübingen, Tübingen, Germany., Pichler BJ; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) partner site Tübingen, Tübingen, Germany., Sonanini D; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, University of Tübingen, Tübingen, Germany.; Department of Medical Oncology and Pneumology, University of Tübingen, Tübingen, Germany., Rothbauer U; Pharmaceutical Biotechnology, University Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany. |
| Source: | Frontiers in immunology [Front Immunol] 2024 Oct 15; Vol. 15, pp. 1480091. Date of Electronic Publication: 2024 Oct 15 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
